Positive and Negative Allosteric Modulators of N-Methyl- d -aspartate (NMDA) Receptors

Structure-Activity Relationships and Mechanisms of Action

Erica S. Burnell, Mark Irvine, Guangyu Fang, Kiran Sapkota, David E. Jane, Daniel T Monaghan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Excitatory activity in the CNS is predominately mediated by l-glutamate through several families of l-glutamate neurotransmitter receptors. Of these, the N-methyl-d-aspartate receptor (NMDAR) family has many critical roles in CNS function and in various neuropathological and psychiatric conditions. Until recently, the types of compounds available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biological effect. However, several new classes of NMDAR agents have now been identified that are positive or negative allosteric modulators (PAMs and NAMs, respectively) with various patterns of NMDAR subtype selectivity. These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacological control over NMDAR activity than previously available agents. The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.

Original languageEnglish (US)
Pages (from-to)3-23
Number of pages21
JournalJournal of Medicinal Chemistry
Volume62
Issue number1
DOIs
StatePublished - Oct 1 2019

Fingerprint

Structure-Activity Relationship
Neurotransmitter Receptor
Glutamate Receptors
aspartic acid receptor
Psychiatry
Glutamic Acid
Binding Sites
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Positive and Negative Allosteric Modulators of N-Methyl- d -aspartate (NMDA) Receptors : Structure-Activity Relationships and Mechanisms of Action. / Burnell, Erica S.; Irvine, Mark; Fang, Guangyu; Sapkota, Kiran; Jane, David E.; Monaghan, Daniel T.

In: Journal of Medicinal Chemistry, Vol. 62, No. 1, 01.10.2019, p. 3-23.

Research output: Contribution to journalArticle

@article{81f9531ec45f4d4787f031cb5a0aa10b,
title = "Positive and Negative Allosteric Modulators of N-Methyl- d -aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action",
abstract = "Excitatory activity in the CNS is predominately mediated by l-glutamate through several families of l-glutamate neurotransmitter receptors. Of these, the N-methyl-d-aspartate receptor (NMDAR) family has many critical roles in CNS function and in various neuropathological and psychiatric conditions. Until recently, the types of compounds available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biological effect. However, several new classes of NMDAR agents have now been identified that are positive or negative allosteric modulators (PAMs and NAMs, respectively) with various patterns of NMDAR subtype selectivity. These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacological control over NMDAR activity than previously available agents. The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.",
author = "Burnell, {Erica S.} and Mark Irvine and Guangyu Fang and Kiran Sapkota and Jane, {David E.} and Monaghan, {Daniel T}",
year = "2019",
month = "10",
day = "1",
doi = "10.1021/acs.jmedchem.7b01640",
language = "English (US)",
volume = "62",
pages = "3--23",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Positive and Negative Allosteric Modulators of N-Methyl- d -aspartate (NMDA) Receptors

T2 - Structure-Activity Relationships and Mechanisms of Action

AU - Burnell, Erica S.

AU - Irvine, Mark

AU - Fang, Guangyu

AU - Sapkota, Kiran

AU - Jane, David E.

AU - Monaghan, Daniel T

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Excitatory activity in the CNS is predominately mediated by l-glutamate through several families of l-glutamate neurotransmitter receptors. Of these, the N-methyl-d-aspartate receptor (NMDAR) family has many critical roles in CNS function and in various neuropathological and psychiatric conditions. Until recently, the types of compounds available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biological effect. However, several new classes of NMDAR agents have now been identified that are positive or negative allosteric modulators (PAMs and NAMs, respectively) with various patterns of NMDAR subtype selectivity. These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacological control over NMDAR activity than previously available agents. The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.

AB - Excitatory activity in the CNS is predominately mediated by l-glutamate through several families of l-glutamate neurotransmitter receptors. Of these, the N-methyl-d-aspartate receptor (NMDAR) family has many critical roles in CNS function and in various neuropathological and psychiatric conditions. Until recently, the types of compounds available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biological effect. However, several new classes of NMDAR agents have now been identified that are positive or negative allosteric modulators (PAMs and NAMs, respectively) with various patterns of NMDAR subtype selectivity. These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacological control over NMDAR activity than previously available agents. The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.

UR - http://www.scopus.com/inward/record.url?scp=85059506923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059506923&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.7b01640

DO - 10.1021/acs.jmedchem.7b01640

M3 - Article

VL - 62

SP - 3

EP - 23

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 1

ER -